<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Metabolic-Microbiome Cross-Talk: Obesity, T2DM, and Dysbiosis</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #111827;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #000;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f9fafb;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #059669;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Stats Highlight */
        .stat-highlight {
            color: #059669;
            font-weight: 700;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* References & Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fafafa;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #374151;
        }

        .references-box ul {
            padding-left: 20px;
            color: #6b7280;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 18: Integration & Synthesis</p>
            <h1 class="lesson-title">Metabolic-Microbiome Cross-Talk: The Triad of Obesity, T2DM, and Dysbiosis</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Level 2 Advanced Integration</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#endotoxemia"><span class="section-num">1</span>Metabolic Endotoxemia & TLR-4</a></li>
                <li><a href="#incretins"><span class="section-num">2</span>The Incretin Connection (GLP-1)</a></li>
                <li><a href="#diversity"><span class="section-num">3</span>Beyond the F/B Ratio</a></li>
                <li><a href="#bile-acids"><span class="section-num">4</span>Bile Acid Signaling: TGR5 & FXR</a></li>
                <li><a href="#akkermansia"><span class="section-num">5</span>Akkermansia & Weight Management</a></li>
                <li><a href="#protocols"><span class="section-num">6</span>Advanced Metabolic Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Deconstruct the molecular pathway of LPS-induced TLR-4 activation and its role in systemic insulin resistance.</li>
                <li>Analyze how microbial metabolites modulate the secretion of GLP-1 and GIP for glycemic control.</li>
                <li>Evaluate the clinical significance of microbial gene richness versus simple taxonomic ratios in metabolic syndrome.</li>
                <li>Explain the role of TGR5 and FXR receptors in the gut-liver-adipose axis.</li>
                <li>Design targeted interventions using <i>Akkermansia muciniphila</i> and specific polyphenols for metabolic optimization.</li>
            </ul>
        </div>

        <h2 id="endotoxemia">1. Metabolic Endotoxemia: The Silent Driver of Insulin Resistance</h2>
        <p>In previous modules, we established the concept of "leaky gut" or intestinal permeability. At the L2 level, we must transition from a conceptual understanding to a molecular one. The primary mediator of metabolic inflammation is <span class="highlight">Lipopolysaccharide (LPS)</span>, a structural component of the cell wall of Gram-negative bacteria.</p>
        
        <p>When the intestinal barrier is compromised‚Äîoften due to a high-fat, low-fiber diet‚ÄîLPS translocates into the portal circulation. This phenomenon, known as <span class="highlight">metabolic endotoxemia</span>, increases plasma LPS levels by <span class="stat-highlight">2 to 3-fold</span>, a concentration high enough to trigger chronic low-grade inflammation but low enough to avoid septic shock. A landmark study by Cani et al. (2007) demonstrated that chronic subcutaneous infusion of LPS in mice induced the same weight gain and insulin resistance as a high-fat diet, proving that LPS is a primary causative factor.</p>

        <div class="principle-card" style="border-left: 5px solid #059669; background: #f0fdf4; padding: 20px; border-radius: 8px; margin: 20px 0;">
            <p style="margin: 0; font-weight: 600; color: #065f46;">The TLR-4 Mechanism:</p>
            <p style="margin: 5px 0 0 0; font-size: 15px;">LPS binds to <b>Toll-Like Receptor 4 (TLR-4)</b> on the surface of macrophages and adipocytes. This activation triggers the NF-Œ∫B pathway, leading to the production of pro-inflammatory cytokines like TNF-Œ± and IL-6. These cytokines interfere with the <b>Insulin Receptor Substrate 1 (IRS-1)</b>, effectively "blunting" the cell's response to insulin.</p>
        </div>

        <h2 id="incretins">2. Microbial Modulation of Incretins: GLP-1 and GIP</h2>
        <p>The gut is the body's largest endocrine organ. Two critical hormones, <span class="highlight">Glucagon-like Peptide-1 (GLP-1)</span> and <span class="highlight">Glucose-dependent Insulinotropic Polypeptide (GIP)</span>, are responsible for the "incretin effect"‚Äîthe phenomenon where oral glucose triggers a significantly higher insulin response than intravenous glucose.</p>
        
        <p>The microbiome influences these hormones through several pathways:</p>
        <ul>
            <li><b>Short-Chain Fatty Acids (SCFAs):</b> Butyrate and propionate bind to G-protein coupled receptors (GPR41 and GPR43) on enteroendocrine L-cells, stimulating the release of GLP-1.</li>
            <li><b>Indole Derivatives:</b> Tryptophan metabolism by certain bacteria produces indoles that modulate GLP-1 secretion.</li>
            <li><b>Akkermansia muciniphila:</b> This keystone species produces a protein (Amuc_1100) that has been shown to improve glucose tolerance by interacting with TLR-2 and increasing GLP-1 levels.</li>
        </ul>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Metabolite/Taxa</th>
                        <th>Target Receptor</th>
                        <th>Metabolic Outcome</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Butyrate (SCFA)</td>
                        <td>GPR41 / GPR43</td>
                        <td>‚Üë GLP-1, ‚Üë Satiety, ‚Üì Inflammation</td>
                    </tr>
                    <tr>
                        <td>LPS (Endotoxin)</td>
                        <td>TLR-4</td>
                        <td>‚Üë Insulin Resistance, ‚Üë Adipocyte hypertrophy</td>
                    </tr>
                    <tr>
                        <td>Secondary Bile Acids</td>
                        <td>TGR5</td>
                        <td>‚Üë Energy expenditure, ‚Üë GLP-1 secretion</td>
                    </tr>
                    <tr>
                        <td>A. muciniphila</td>
                        <td>TLR-2 / Mucus layer</td>
                        <td>‚Üë Barrier integrity, ‚Üë Insulin sensitivity</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="diversity">3. Beyond the F/B Ratio: The Gene Richness Paradigm</h2>
        <p>Early microbiome research focused heavily on the <span class="highlight">Firmicutes to Bacteroidetes (F/B) ratio</span>, suggesting that an increased ratio was a hallmark of obesity. However, meta-analyses of human studies have shown inconsistent results. Advanced practitioners now look toward <span class="highlight">Microbial Gene Richness (MGR)</span>.</p>
        
        <p>Individuals with "Low Gene Count" (LGC) microbiomes are characterized by higher body fat percentages, increased insulin resistance, and more pronounced pro-inflammatory markers compared to "High Gene Count" (HGC) individuals. A 2013 study (Le Chatelier et al.) found that <span class="stat-highlight">approx. 23% of the population</span> has low microbial richness, making them significantly more susceptible to metabolic complications even if their BMI is currently within a normal range.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The "TOFI" Client</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Thin Outside, Fat Inside (Metabolic Dysbiosis)</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">D</div>
                    <div class="patient-info">
                        <h4>David, 42</h4>
                        <p>BMI: 24.5 (Normal) | HbA1c: 5.9% (Prediabetic) | High Visceral Fat</p>
                    </div>
                </div>
                <p><b>Presentation:</b> David presented with fatigue and "brain fog" despite a seemingly healthy weight. Stool analysis revealed low <i>Akkermansia</i> (below 0.1%) and low microbial diversity (Shannon Index: 2.1).</p>
                <p><b>Intervention:</b> Utilizing <span class="highlight">The Method's</span> metabolic track, we introduced 10g/day of partially hydrolyzed guar gum (PHGG) and 500mg of pomegranate extract (ellagitannins) to stimulate <i>Akkermansia</i> growth.</p>
                <p><b>Outcome:</b> After 12 weeks, David's HbA1c dropped to 5.4%, and his <i>Akkermansia</i> levels rose to 3.2%. His visceral fat area decreased by <span class="stat-highlight">14%</span> without significant change in total body weight, highlighting the microbiome's role in body composition.</p>
            </div>
        </div>

        <h2 id="bile-acids">4. Bile Acid Signaling: The Gut-Liver-Metabolic Bridge</h2>
        <p>Bile acids are no longer viewed simply as "detergents" for fat digestion; they are potent signaling molecules. The microbiome performs a critical step: converting primary bile acids (produced by the liver) into <span class="highlight">secondary bile acids</span> (like lithocholic acid and deoxycholic acid).</p>
        
        <p>These secondary bile acids act as ligands for two major receptors:</p>
        <ul>
            <li><b>FXR (Farnesoid X Receptor):</b> Regulates bile acid synthesis, lipid metabolism, and glucose homeostasis. Dysbiosis can lead to over-inhibition of FXR, contributing to Non-Alcoholic Fatty Liver Disease (NAFLD).</li>
            <li><b>TGR5 (G protein-coupled bile acid receptor 1):</b> Located in the muscle and brown adipose tissue. Activation of TGR5 increases mitochondrial energy expenditure and triggers GLP-1 release.</li>
        </ul>
        <p>A lack of specific bacteria capable of deconjugating bile acids (like certain <i>Lactobacillus</i> and <i>Bacteroides</i> species) disrupts this signaling, leading to a "sluggish" metabolism and increased fat storage.</p>

        <h2 id="akkermansia">5. Akkermansia muciniphila: The Metabolic Guardian</h2>
        <p>If there is one species that embodies the metabolic-microbiome cross-talk, it is <i>Akkermansia muciniphila</i>. Accounting for <span class="stat-highlight">1-4% of the total microbiome</span> in healthy adults, its abundance is inversely correlated with obesity and Type 2 Diabetes.</p>
        
        <p><i>Akkermansia</i> lives in the mucus layer of the gut. By "grazing" on mucus, it stimulates the goblet cells to produce more, creating a robust physical barrier. This prevents LPS translocation. Clinically, low levels of <i>Akkermansia</i> are a strong predictor of poor response to weight loss interventions. In a 2019 pilot study (Depommier et al.), pasteurized <i>Akkermansia</i> supplementation in overweight volunteers led to significant improvements in insulin sensitivity and a <span class="stat-highlight">30% reduction</span> in plasma LPS levels.</p>

        <h2 id="protocols">6. Developing Metabolic-Focused Protocols</h2>
        <p>As an AccrediPro Practitioner, your interventions for metabolic health must go beyond "eat more fiber." We use a precision approach based on the <b>Triad of Metabolic Recovery</b>:</p>

        <div class="principle-card">
            <div class="principle-title">1. Polyphenol Loading for Akkermansia</div>
            <p class="principle-text">Polyphenols act as selective prebiotics. Epigallocatechin gallate (EGCG) from green tea and anthocyanins from berries specifically increase <i>Akkermansia</i> and <i>Christensenellaceae</i>, both associated with lean phenotypes.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">2. Circadian Chrononutrition</div>
            <p class="principle-text">The microbiome has its own circadian rhythm. Eating in a restricted window (e.g., 10/14) allows the "night shift" bacteria like <i>Akkermansia</i> to thrive and repair the gut lining without interference from dietary fats.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">3. Targeted SCFA Production</div>
            <p class="principle-text">Use Resistant Starch Type 2 (RS2) or Acetylated Starch to specifically target butyrate production in the distal colon, maximizing GLP-1 secretion and reducing systemic inflammation.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the metabolic-microbiome triad.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">How does metabolic endotoxemia contribute to insulin resistance at the cellular level?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">LPS translocates across the gut barrier and binds to TLR-4 receptors on macrophages and adipocytes. This activates the NF-Œ∫B pro-inflammatory pathway, which produces cytokines that interfere with IRS-1 (Insulin Receptor Substrate 1), blunting the cell's response to insulin.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">True or False: The Firmicutes/Bacteroidetes ratio is the most reliable clinical marker for predicting metabolic syndrome success.</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">False. While the F/B ratio was an early focus, Microbial Gene Richness (MGR) and the presence of keystone species like <i>Akkermansia muciniphila</i> are now considered more accurate and clinically relevant markers for metabolic health.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><b>LPS is a Metabolic Toxin:</b> Systemic insulin resistance is often driven by the translocation of LPS through a compromised intestinal barrier.</li>
                <li><b>The Incretin Effect:</b> Gut microbes modulate GLP-1 and GIP through SCFAs and specialized proteins, directly influencing postprandial glucose.</li>
                <li><b>Akkermansia as a Metric:</b> This keystone species is essential for barrier integrity and is a primary target for metabolic restoration protocols.</li>
                <li><b>Bile Acid Signaling:</b> The conversion of primary to secondary bile acids by the microbiome is a key regulator of mitochondrial energy expenditure via TGR5.</li>
                <li><b>Precision Interventions:</b> Effective metabolic coaching requires a combination of specific polyphenols, fiber diversity, and circadian alignment.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Cani, P. D., et al. (2007). "Metabolic Endotoxemia Initiates Obesity and Insulin Resistance." <i>Diabetes</i>.</li>
                <li>Depommier, C., et al. (2019). "Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study." <i>Nature Medicine</i>.</li>
                <li>Le Chatelier, E., et al. (2013). "Richness of human gut microbiome correlates with metabolic markers." <i>Nature</i>.</li>
                <li>Belzer, C., & de Vos, W. M. (2012). "Microbes inside‚Äîfrom diversity to function: the case of Akkermansia muciniphila." <i>The ISME Journal</i>.</li>
                <li>Everard, A., et al. (2013). "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity." <i>Proceedings of the National Academy of Sciences (PNAS)</i>.</li>
                <li>Thomas, C., et al. (2009). "TGR5-mediated bile acid sensing controls glucose homeostasis." <i>Cell Metabolism</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Gut Health & Microbiome Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>